Bone loss after bariatric surgery: Causes, consequences, and management

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 2, 2014, Pages 165-174

  Stein, Emily M ^a   Silverberg, Shonni J ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; BARIATRIC SURGERY; BONE DENSITY; COMPLICATION; ETIOLOGY; HUMAN; MALNUTRITION; OSTEOLYSIS; WEIGHT REDUCTION;

BARIATRIC SURGERY; BONE DENSITY; BONE RESORPTION; HUMANS; MALNUTRITION; WEIGHT LOSS;

EID: 84893403500     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70183-9     Document Type: Review

References (111)

1. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract 2013, 19:337-372.
2. Buchwald H, Oien DM Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009, 19:1605-1611.
3. Brolin RE Bariatric surgery and long-term control of morbid obesity. JAMA 2002, 288:2793-2796.
4. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012, 366:1567-1576.
5. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012, 366:1577-1585.
6. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741-752. for the Swedish Obese Subjects Study.
7. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007, 357:753-761.
8. Stein EM, Carrelli A, Young P, et al. Bariatric surgery results in cortical bone loss. J Clin Endocrinol Metab 2013, 98:541-549.
9. Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 2008, 93:3735-3740.
10. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004, 89:1061-1065.
11. Jones DB, Schneider BE, Olbers T Atlas of metabolic and weight loss surgery 2010, Cine-Med, Woodbury, CT.
12. Stein EM, Strain G, Sinha N, et al. Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin Endocrinol (Oxf) 2009, 71:176-183.
13. Censani M, Stein EM, Shane E, et al. Vitamin D Deficiency is prevalent in morbidly obese adolescents prior to bariatric surgery. ISRN Obes 2013, 2013:284516.
14. Hyppönen E, Power C Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007, 85:860-868.
15. Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 1981, 34:2359-2363.
16. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72:690-693.
17. Grethen E, Hill KM, Jones R, et al. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab 2012, 97:1655-1662.
18. Flores L, Osaba MJ, Andreu A, Moizé V, Rodríguez L, Vidal J Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism. Obes Surg 2010, 20:738-743.
19. Reid IR Relationships between fat and bone. Osteoporos Int 2008, 19:595-606.
20. Nielson CM, Srikanth P, Orwoll ES Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res 2012, 27:1-10.
21. Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006, 83:146-154.
22. Schellinger D, Lin CS, Lim J, Hatipoglu HG, Pezzullo JC, Singer AJ Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: their ratio as a new indicator of bone weakening. AJR Am J Roentgenol 2004, 183:1761-1765.
23. Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 2009, 94:3387-3393.
24. Cohen A, Dempster DW, Recker RR, et al. Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab 2013, 98:2562-2572.
25. Johansson H, Kanis JA, Odén A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res 2013, published online June 17. 10.1002/jbmr.2017.
26. Sornay-Rendu E, Boutroy S, Vilayphiou N, Claustrat B, Chapurlat RD In obese postmenopausal women, bone microarchitecture and strength are not commensurate to greater body weight: the Os des Femmes de Lyon (OFELY) study. J Bone Miner Res 2013, 28:1679-1687.
27. Compston JE, Watts NB, Chapurlat R, et al. Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med 2011, 124:1043-1050. the Glow Investigators.
28. Goulding A, Grant AM, Williams SM Bone and body composition of children and adolescents with repeated forearm fractures. J Bone Miner Res 2005, 20:2090-2096.
29. Premaor MO, Pilbrow L, Tonkin C, Parker RA, Compston J Obesity and fractures in postmenopausal women. J Bone Miner Res 2010, 25:292-297.
30. Compston JE, Flahive J, Hosmer DW, et al. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res 2013, for the for the GLOW Investigators, published online July 22. 10.1002/jbmr.2051.
31. Marcus RL, Addison O, Dibble LE, Foreman KB, Morrell G, Lastayo P Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals. J Aging Res 2012, 2012:629637.
32. Premaor MO, Compston JE, Fina Avilés F, et al. The association between fracture site and obesity in men: a population-based cohort study. J Bone Miner Res 2013, 28:1771-1777.
33. Binkley N, Krueger D, Vallarta-Ast N An overlying fat panniculus affects femur bone mass measurement. J Clin Densitom 2003, 6:199-204.
34. Yu EW, Thomas BJ, Brown JK, Finkelstein JS Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. J Bone Miner Res 2012, 27:119-124.
35. Knapp KM, Welsman JR, Hopkins SJ, Fogelman I, Blake GM Obesity increases precision errors in dual-energy X-ray absorptiometry measurements. J Clin Densitom 2012, 15:315-319.
36. Madsen OR, Jensen JE, Sørensen OH Validation of a dual energy X-ray absorptiometer: measurement of bone mass and soft tissue composition. Eur J Appl Physiol Occup Physiol 1997, 75:554-558.
37. Yu EW, Thomas BJ, Brown JK, Finkelstein JS Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. J Bone Miner Res 2012, 27:119-124.
38. Colt E, Akram M, Javed F, Shane E, Boutroy S Comparison of the effect of surrounding fat on measurements of BMD by DXA and high resolution quantitative computerized tomography (accessed Dec 10, 2013). http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=41a0e91b-7391-4e12-a4ae-4940e1520130.
39. Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol 2011, 8:429-437.
40. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
41. Romy S, Donadini A, Giusti V, Suter M Roux-en-Y gastric bypass vs gastric banding for morbid obesity: a case-matched study of 442 patients. Arch Surg 2012, 147:460-466.
42. Suter M, Calmes JM, Paroz A, Giusti V A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg 2006, 16:829-835.
43. Giusti V, Gasteyger C, Suter M, Heraief E, Gaillard RC, Burckhardt P Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up. Int J Obes (Lond) 2005, 29:1429-1435.
44. Pugnale N, Giusti V, Suter M, et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes Relat Metab Disord 2003, 27:110-116.
45. Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?. J Clin Endocrinol Metab 2002, 87:1184-1188.
46. Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 2003, 13:383-388.
47. von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism 2004, 53:918-921.
48. Cundy T, Evans MC, Kay RG, Dowman M, Wattie D, Reid IR Effects of vertical-banded gastroplasty on bone and mineral metabolism in obese patients. Br J Surg 1996, 83:1468-1472.
49. Ruiz-Tovar J, Oller I, Priego P, et al. Short- and mid-term changes in bone mineral density after laparoscopic sleeve gastrectomy. Obes Surg 2013, 23:861-866.
50. Brzozowska MM, Sainsbury A, Eisman JA, Baldock PA, Center JR Bariatric surgery, bone loss, obesity and possible mechanisms. Obes Rev 2013, 14:52-67.
51. Nogués X, Goday A, Peña MJ, et al. Bone mass loss after sleeve gastrectomy: a prospective comparative study with gastric bypass. Cir Esp 2010, 88:103-109. (in Spanish).
52. Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011, 254:410-420.
53. Demaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg 2010, 252:559-566.
54. Pluskiewicz W, Bužga M, Holéczy P, Bortlík L, Šmajstrla V, Adamczyk P Bone mineral changes in spine and proximal femur in individual obese women after laparoscopic sleeve gastrectomy: a short-term study. Obes Surg 2012, 22:1068-1076.
55. Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 2009, 250:631-641.
56. Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc 2012, 26:1909-1919.
57. Riedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 2006, 14:1940-1948.
58. Casagrande DS, Repetto G, Mottin CC, et al. Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes Surg 2012, 22:1287-1292.
59. Youssef Y, Richards WO, Sekhar N, et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc 2007, 21:1393-1396.
60. De Prisco C, Levine SN Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 2005, 329:57-61.
61. El-Kadre LJ, Rocha PR, de Almeida Tinoco AC, Tinoco RC Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2004, 14:1062-1066.
62. Vilarrasa N, San José P, García I, et al. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg 2011, 21:465-472.
63. Yu EW, Bouxsein M, Roy AE, et al. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density. J Bone Miner Res 2013, published online Aug 8. 10.1002/jbmr.2063.
64. Bruno C, Fulford AD, Potts JR, et al. Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab 2010, 95:159-166.
65. Ott MT, Fanti P, Malluche HH, et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 1992, 2:341-348.
66. Goode LR, Brolin RE, Chowdhury HA, Shapses SA Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res 2004, 12:40-47.
67. Carrasco F, Ruz M, Rojas P, et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg 2009, 19:41-46.
68. Vilarrasa N, Gómez JM, Elio I, et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg 2009, 19:860-866.
69. Pereira FA, de Castro JA, dos Santos JE, Foss MC, Paula FJ Impact of marked weight loss induced by bariatric surgery on bone mineral density and remodeling. Braz J Med Biol Res 2007, 40:509-517.
70. Sinha N, Shieh A, Stein EM, et al. Increased PTH and 1.25(OH)(2)D levels associated with increased markers of bone turnover following bariatric surgery. Obesity (Silver Spring) 2011, 19:2388-2393.
71. Johnson JM, Maher JW, Samuel I, Heitshusen D, Doherty C, Downs RW Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg 2005, 9:1106-1110.
72. Olbers T, Björkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg 2006, 244:715-722.
73. Vilarrasa N, de Gordejuela AG, Gómez-Vaquero C, et al. Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy. Obes Surg 2013, 23:2086-2091.
74. Tsiftsis DD, Mylonas P, Mead N, Kalfarentzos F, Alexandrides TK Bone mass decreases in morbidly obese women after long limb-biliopancreatic diversion and marked weight loss without secondary hyperparathyroidism. A physiological adaptation to weight loss?. Obes Surg 2009, 19:1497-1503.
75. Hewitt S, Søvik TT, Aasheim ET, et al. Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch. Obes Surg 2013, 23:384-390.
76. Feng JJ, Gagner M Laparoscopic biliopancreatic diversion with duodenal switch. Semin Laparosc Surg 2002, 9:125-129.
77. Newbury L, Dolan K, Hatzifotis M, Low N, Fielding G Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003, 13:893-895.
78. Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004, 8:48-55.
79. Moreiro J, Ruiz O, Perez G, et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg 2007, 17:348-354.
80. Marceau P, Biron S, Lebel S, et al. Does bone change after biliopancreatic diversion?. J Gastrointest Surg 2002, 6:690-698.
81. Aasheim ET, Hofsø D, Søvik TT Vitamin supplements after bariatric surgery. Clin Endocrinol (Oxf) 2010, 72:134-135.
82. Compston JE, Vedi S, Gianetta E, Watson G, Civalleri D, Scopinaro N Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology 1984, 87:350-356.
83. Cheung AM, Detsky AS Osteoporosis and fractures: missing the bridge?. JAMA 2008, 299:1468-1470.
84. Lalmohamed A, de Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ 2012, 345:e5085.
85. Frost HM Bone "mass" and the "mechanostat": a proposal. Anat Rec 1987, 219:1-9.
86. Maïmoun L, Fattal C, Micallef JP, Peruchon E, Rabischong P Bone loss in spinal cord-injured patients: from physiopathology to therapy. Spinal Cord 2006, 44:203-210.
87. Zerwekh JE, Ruml LA, Gottschalk F, Pak CY The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res 1998, 13:1594-1601.
88. Salamone LM, Cauley JA, Black DM, et al. Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial. Am J Clin Nutr 1999, 70:97-103.
89. Riedt CS, Cifuentes M, Stahl T, Chowdhury HA, Schlussel Y, Shapses SA Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake. J Bone Miner Res 2005, 20:455-463.
90. Schwartz AV, Johnson KC, Kahn SE, et al. Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial. J Bone Miner Res 2012, 27:619-627. for the Look AHEAD Research Group.
91. Jensen LB, Kollerup G, Quaade F, Sørensen OH Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation. J Bone Miner Res 2001, 16:141-147.
92. Ricci TA, Chowdhury HA, Heymsfield SB, Stahl T, Pierson RN, Shapses SA Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women. J Bone Miner Res 1998, 13:1045-1050.
93. Bergmann G, Deuretzbacher G, Heller M, et al. Hip contact forces and gait patterns from routine activities. J Biomech 2001, 34:859-871.
94. Shaker JL, Norton AJ, Woods MF, Fallon MD, Findling JW Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos Int 1991, 1:177-181.
95. Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado-Mendoza R, Muscogiuri G Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes (Lond) 2012, 36:1373-1379.
96. Deitel M Bariatric surgery, proton pump inhibitors, and possibility of osteoporosis. Surg Obes Relat Dis 2010, 6:461-462.
97. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
98. Carlin AM, Rao DS, Yager KM, Parikh NJ, Kapke A Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis 2009, 5:444-449.
99. Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989, 4:283-291.
100. Michalakis K, le Roux C Gut hormones and leptin: impact on energy control and changes after bariatric surgery-what the future holds. Obes Surg 2012, 22:1648-1657.
101. Korner J, Inabnet W, Febres G, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009, 33:786-795.
102. Reid IR Relationships among body mass, its components, and bone. Bone 2002, 31:547-555.
103. Oshima K, Nampei A, Matsuda M, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005, 331:520-526.
104. Wong IP, Driessler F, Khor EC, et al. Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS One 2012, 7:e40038.
105. Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008, 93:2737.
106. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol 2013, 168:829-843.
107. Berarducci A, Haines K, Murr MM Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res 2009, 22:35-41.
108. Nakamura KM, Haglind EG, Clowes JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int 2013, published online Aug 3. 10.1007/s00198-013-2463-x.
109. da Rosa CL, Dames Olivieri Saubermann AP, Jacqueline J, Pereira SE, Saboya C, Ramalho A Routine supplementation does not warrant the nutritional status of vitamin D adequate after gastric bypass Roux-en-Y. Nutr Hosp 2013, 28:169-172.
110. Goldner WS, Stoner JA, Lyden E, et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg 2009, 19:173-179.
111. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010, 95:4823-4843. for the Endocrine Society.